WHABT as mentioned above. 3. Increase in trade and other payables of THB 979.9 mm, mainly due to the cash received from WHA-W1 exercise before paid-up the capital. 4. Increase in deferred tax of THB 430.6

COMPANY LIMITED MANAGEMENT DISCUSSION AND ANALYSIS FOR Q2/2019 6 7. FINANCIAL POSITION ANALYSIS (Cont.) - Account payables were 274.97 million Baht, increased by 127.76 million Baht from discount for PWA

short-term loans from financial institutions for dividend payment on 3 April 2019; (2) dividend payables of THB 1,250.0 million. However, the Company has already paid the dividend in full on 11 July 2019

Short term loans from banks 72.77 3.20% 92.25 3.93% Account payables, trade and others 451.29 19.81% 516.82 22.03% Income tax payable 28.56 1.25% 20.12 0.86% Other current liabilities 8.69 0.38% 8.56 0.37

-current assets 588 577 1.8% Total non-current assets 2,730 2,807 (3%) Total Assets 4,489 4,705 (5%) Bank overdrafts and short-term loans from financial institutions 1,456 1,512 (4%) Account payables 429 433

receivables before allowance for doubtful account / (Total revenue from sales / Number of days in the period 1 ) Accounts payable (days) = Average account payables / (Cost of sales of goods / Number of days in

net loss of Bt129mn in 1Q18. The gain was incurred from partially-hedge CAPEX payables following currency fluctuation. Finance cost was Bt1,290mn decreasing 2.6% YoY from lower interest-bearing debt and

December 2017. This was largely due to (i) long-term loans from related parties and interest payables of THB 5,025mn, or the outstanding debt assumed from the EBT of UE and (ii) an increase in current

, advances and deposits received from customers of 3,469 million Baht, and trade and other payables of 3,069 million Baht. The main assets were 92% of the total assets. Shareholders’ Equity As at 30 June 2018

121.10 5.18% 35.84 1.52% Account payables, trade and others 479.39 20.49% 563.80 23.87% Income tax payable 24.69 1.06% 30.95 1.31% Other current liabilities 4.32 0.18% 10.33 0.43% Total current liabilities